Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
6.26
-0.47 (-6.98%)
At close: Apr 1, 2025, 4:00 PM
6.30
+0.04 (0.64%)
After-hours: Apr 1, 2025, 7:55 PM EDT

Immunome Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-292.96-106.81-36.9-24.71-17.84
Upgrade
Depreciation & Amortization
2.10.730.630.760.76
Upgrade
Asset Writedown & Restructuring Costs
152.3480.8---
Upgrade
Loss (Gain) From Sale of Investments
-2.9-0.51---
Upgrade
Stock-Based Compensation
15.756.225.333.450.62
Upgrade
Other Operating Activities
----0.55.54
Upgrade
Change in Accounts Payable
9.53-0.61-0.681.780.5
Upgrade
Change in Unearned Revenue
-9.0415.98---
Upgrade
Change in Other Net Operating Assets
14.39-3.382.921-1.71
Upgrade
Operating Cash Flow
-110.79-7.57-28.69-18.23-12.13
Upgrade
Capital Expenditures
-53.51-0.83-0.25-0.08-0.59
Upgrade
Cash Acquisitions
-9.28---
Upgrade
Investment in Securities
-31.56-38.93---
Upgrade
Investing Cash Flow
-85.06-30.48-0.25-0.08-0.59
Upgrade
Long-Term Debt Issued
----0.5
Upgrade
Long-Term Debt Repaid
----0.11-0.45
Upgrade
Net Debt Issued (Repaid)
----0.110.05
Upgrade
Issuance of Common Stock
255.760.410.0328.6644.87
Upgrade
Other Financing Activities
-15.23116--0.78-6.02
Upgrade
Financing Cash Flow
240.53116.410.0327.7749.94
Upgrade
Net Cash Flow
44.6778.36-28.919.4637.22
Upgrade
Free Cash Flow
-164.3-8.4-28.94-18.31-12.72
Upgrade
Free Cash Flow Margin
-1817.30%-59.92%---
Upgrade
Free Cash Flow Per Share
-2.80-0.42-2.39-1.59-3.75
Upgrade
Cash Interest Paid
---0.010.03
Upgrade
Levered Free Cash Flow
-96.32-1.65-14.89-8.75-8.1
Upgrade
Unlevered Free Cash Flow
-96.32-1.65-14.89-8.74-8.08
Upgrade
Change in Net Working Capital
-35.25-10.18-2.46-2.891.2
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q